The Development of Al(18)F-NOTA-FAP-2286 as an FAP-Targeted PET Tracer and the Translational Application in the Diagnosis of Acquired Drug Resistance in Progressive Prostate Cancer.

Du X, Zhang Y, Jia Y, Gao B

Open source

DOI
10.3390/pharmaceutics17050552
Published
2025 Apr 23
Container
Pharmaceutics
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/pharmaceutics17050552,
  title = {The Development of Al(18)F-NOTA-FAP-2286 as an FAP-Targeted PET Tracer and the Translational Application in the Diagnosis of Acquired Drug Resistance in Progressive Prostate Cancer.},
  author = {Du X and Zhang Y and Jia Y and Gao B},
  year = {2025},
  journal = {Pharmaceutics},
  doi = {10.3390/pharmaceutics17050552},
  url = {https://doi.org/10.3390/pharmaceutics17050552}
}

RIS

TY  - JOUR
TI  - The Development of Al(18)F-NOTA-FAP-2286 as an FAP-Targeted PET Tracer and the Translational Application in the Diagnosis of Acquired Drug Resistance in Progressive Prostate Cancer.
AU  - Du X
AU  - Zhang Y
AU  - Jia Y
AU  - Gao B
PY  - 2025
JO  - Pharmaceutics
DO  - 10.3390/pharmaceutics17050552
UR  - https://doi.org/10.3390/pharmaceutics17050552
ER  - 

APA

X, D., Y, Z., Y, J., & B, G. (2025). The Development of Al(18)F-NOTA-FAP-2286 as an FAP-Targeted PET Tracer and the Translational Application in the Diagnosis of Acquired Drug Resistance in Progressive Prostate Cancer.. Pharmaceutics. https://doi.org/10.3390/pharmaceutics17050552

Source records